Organizer: International AIDS Society Speakers: (Chair) Adeeba Kamarulzaman, IAS President-Elect Anthony Fauci, Director, National Institute of Allergy & Infectious Diseases Claudio Fenizia, Postdoctoral Researcher, University of Milan: In-utero mother-to-child SARS-CoV-2 transmission – viral detection and fetal immune response Andrew Hill, Senior visiting Research Fellow, Department of Pharmacology, Liverpool University: Sofosbuvir and daclatasvir as a potential candidate for moderate or severe COVID-19 treatment, results from a randomised clinical trial Kristen Marks, Physician, Weill Cornell Medicine: Baseline characteristics associated with clinical improvements and mortality in hospitalized patients with severe COVID-19 treated with remdesivir Carina Marquez, Assistant Professor of Medicine & Associate Director of Education, Division of HIV, Infectious Diseases, and Global Medicine, Zuckerberg San Francisco General Hospital; Associate Director for Equity, UCSF Center for AIDS Research: High prevalence of asymptomatic SARS-CoV-2 infection found in a Latinx population in San Francisco in a mass testing campaign. Please contact media@iasociety.org if you have any questions